The Swiss biopharmaceutical company Light Chain Bioscience has developed a novel and unique class of human, bispecific antibodies dubbed κλ bodies, so-called because they combine a κ light ...
one causing glomerular albumin loss and the other causing monoclonal light chain proteinuria. Our case series has several limitations. First, it was retrospective. Second, it occurred at a single ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback